Clinical Trial Update: Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial of a Rho kinase (ROCK) inhibitor for carotid artery disease was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Stenosis

Drugs mentioned

• Rho kinase (ROCK) inhibitor

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Carotid Stenosis | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29